HomeCompareSKLYF vs JNJ

SKLYF vs JNJ: Dividend Comparison 2026

SKLYF yields 1.18% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SKLYF wins by $1.86M in total portfolio value
10 years
SKLYF
SKLYF
● Live price
1.18%
Share price
$10.70
Annual div
$0.13
5Y div CAGR
89%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.89M
Annual income
$1,467,059.02
Full SKLYF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SKLYF vs JNJ

📍 SKLYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSKLYFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SKLYF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SKLYF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SKLYF
Annual income on $10K today (after 15% tax)
$100.66/yr
After 10yr DRIP, annual income (after tax)
$1,247,000.17/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SKLYF beats the other by $1,243,014.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SKLYF + JNJ for your $10,000?

SKLYF: 50%JNJ: 50%
100% JNJ50/50100% SKLYF
Portfolio after 10yr
$958.2K
Annual income
$735,874.21/yr
Blended yield
76.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SKLYF
No analyst data
Altman Z
2.0
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SKLYF buys
0
JNJ buys
0
No recent congressional trades found for SKLYF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSKLYFJNJ
Forward yield1.18%2.13%
Annual dividend / share$0.13$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR89%28%
Portfolio after 10y$1.89M$30.3K
Annual income after 10y$1,467,059.02$4,689.40
Total dividends collected$1.83M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SKLYF vs JNJ ($10,000, DRIP)

YearSKLYF PortfolioSKLYF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,924$223.81$10,592$272.30+$332.00SKLYF
2$12,120$431.86$11,289$357.73+$831.00SKLYF
3$13,815$846.37$12,123$472.89+$1.7KSKLYF
4$16,486$1,704.03$13,141$629.86+$3.3KSKLYF
5$21,232$3,591.88$14,408$846.81+$6.8KSKLYF
6$30,889$8,170.96$16,021$1,151.60+$14.9KSKLYF
7$54,049$20,997.42$18,122$1,588.22+$35.9KSKLYF
8$122,729$64,896.75$20,930$2,228.20+$101.8KSKLYF
9$391,612$260,292.14$24,792$3,191.91+$366.8KSKLYF
10$1,886,084$1,467,059.02$30,274$4,689.40+$1.86MSKLYF

SKLYF vs JNJ: Complete Analysis 2026

SKLYFStock

Skylark Holdings Co., Ltd. operates restaurants in Japan and internationally. The company also engages in the provision of food services; and related businesses. It operates Western, Chinese, Japanese, Sushi, and Italian restaurants primarily under the Gusto, Bamiyan, Jonathan´s, Syabu-Yo, Yumean, Steak Gusto, Karayoshi, Grazie Gardens, Aiya, Musashino Mori Coffee, S Gusto, Totoyamichi, chawan, Tonkaratei, La Ohana, Yumean Shokudo, GRAND BUFFET, Miwami, Kushi-Yo, Tomato and Onion, Jyu-Jyu Karubi, and FLO PRESTIGE brand names. The company also provides foodstuffs and concession stand products delivery, store cleaning and maintenance, and linen supply services. As of June 30, 2022, it operated 3,085 stores. The company was formerly known as Skylark Co., Ltd. and changed its name to Skylark Holdings Co., Ltd. in July 2018. Skylark Holdings Co., Ltd. was founded in 1962 and is based in Musashino, Japan.

Full SKLYF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SKLYF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SKLYF vs SCHDSKLYF vs JEPISKLYF vs OSKLYF vs KOSKLYF vs MAINSKLYF vs ABBVSKLYF vs MRKSKLYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.